This study highlights the potential of virtual screening and molecular dynamics as powerful tools in the search for novel inhibitors of beta-lactamase enzyme. Further in vitro and in vivo studies are warranted to confirm these findings.
M. Ghatesse, H. Charoute, F. Hmimid and 3 others
Presented at 2nd International e-Health Forum (IeHF 2024), Casablanca, 30–31 October 2024
AI-driven ligand-based design identified stable inhibitors for YCK1 and YCK2 with strong binding affinities and favorable pharmacokinetic profiles. These ligands could serve as leads for developing therapeutic agents targeting kinase…
S. Harrizi, Y. Zaidoune, R. Amal and 5 others
Presented at 2nd International e-Health Forum (IeHF 2024), Casablanca, 30–31 October 2024
